Hypersecretion of luteinising hormone, infertility, and miscarriage.
about
Gonadotrophin-releasing hormone agonist protocols for pituitary suppression in assisted reproductionGonadotrophin therapy for ovulation induction in subfertility associated with polycystic ovary syndromeHuman menopausal gonadotropin versus recombinant follicle stimulation hormone for ovarian stimulation in assisted reproductive cyclesGonadotrophin-releasing hormone agonist protocols for pituitary suppression in assisted reproductionGonadotrophin-releasing hormone agonist protocols for pituitary suppression in assisted reproductive treatmentHuman menopausal gonadotropin versus recombinant follicle stimulation hormone for ovarian stimulation in assisted reproductive cyclesExtra- and intra-ovarian factors in polycystic ovary syndrome: impact on oocyte maturation and embryo developmental competenceRevisiting ovarian hyper stimulation syndrome: Towards OHSS free clinicComparison of highly purified FSH (metrodin-high purity) with pergonal for IVF superovulationHigher urinary bisphenol A concentration is associated with unexplained recurrent miscarriage risk: evidence from a case-control study in eastern ChinaEffect of gonadotropin-releasing hormone antagonists on intrauterine insemination cycles in women with polycystic ovary syndrome: a meta-analysis.Therapeutic strategies for ovulation induction in infertile women with polycystic ovary syndrome.Results from adding recombinant LH for assisted reproductive technology treatment: A randomized control trialFollicle-stimulating hormone and human menopausal gonadotropin for ovarian stimulation in assisted reproduction cycles.Gonadotrophin therapy for ovulation induction in subfertility associated with polycystic ovary syndrome.Improving in vitro maturation of oocytes in the human taking lessons from experiences in animal species.Polycystic ovaries.Clomiphene citrate--end of an era? A mini-review.Metformin reduces abortion in pregnant women with polycystic ovary syndrome.Targeted overexpression of luteinizing hormone in transgenic mice leads to infertility, polycystic ovaries, and ovarian tumors.Spindle and chromosome configurations of in vitro-matured oocytes from polycystic ovary syndrome and ovulatory infertile women: a pilot study.Impact of exogenous gonadotropin stimulation on circulatory and follicular fluid cytokine profilesLuteinizing hormone and its dilemma in ovulation induction.Immunotherapy of habitual abortion.Correlation of endometrial glycodelin expression and pregnancy outcome in cases with polycystic ovary syndrome treated with clomiphene citrate plus metformin: a controlled study.Exogenous hCG activity, but not endogenous LH activity, is positively associated with live birth rates in anovulatory infertility.Circulating LH/hCG receptor (LHCGR) may identify pre-treatment IVF patients at risk of OHSS and poor implantation.Comparison of Endocrine Profile and In Vitro Fertilization Outcome in Patients with PCOS, Ovulatory PCO, or Normal Ovaries.Surgical Approach for Polycystic Ovarian Syndrome in Management of Infertility.Treatment of polycystic ovary patients undergoing IVFReduced in vitro fertilization of human oocytes correlates with raised circulating FSH levels during ovarian stimulation in normogonadotropic women downregulated with GnRH-analoguesA randomized prospective cross-over study of highly purified follicle-stimulating hormone and human menopausal gonadotrophin for ovarian hyperstimulation in women aged 37-41 years.Factors associated with an optimal pregnancy outcome in an oocyte donation programRequirements for human chorionic gonadotropin and recombinant human luteinizing hormone for follicular development and maturationExogenous luteinizing hormone (LH) increases estradiol response patterns in poor responders with low serum LH concentrations.History of oral contraceptive use and risk of spontaneous abortion.Does suppressing luteinising hormone secretion reduce the miscarriage rate? Results of a randomised controlled trial.Is metformin a primary ovulatory agent in patients with polycystic ovary syndrome?Endocrine dysfunction and recurrent spontaneous abortion: An overview.Pregnancy in polycystic ovary syndrome.
P2860
Q24187850-B18B84A8-DA20-4E4F-9985-762EE0C6F368Q24188044-868FB5F0-59E5-4C21-94B0-099D0E4098EAQ24234251-8FE4A4F5-D762-4D37-99FC-8E7FCA80C8CAQ24234909-34BB3EA7-AC73-4880-8481-0C4BCF811E43Q24240778-E3DA7373-CE55-46E9-AD5E-D55639C61902Q24250231-8F29C1FD-6DA4-48CB-A8D5-79D70B5EFE38Q24629523-42543A2C-3F46-451C-83A6-202A0C04FE39Q28084432-5BDBBA23-6DF9-4EE7-BE3A-99E367D9D4FCQ28265421-4AA44007-2E5E-46B6-A6C8-710CF2D15511Q28394824-C30DC8D2-A925-46CB-AB93-A8CDAD41CE5DQ31145069-7C27F326-7274-433F-A0C9-BBBE2F6CD77DQ33230782-E6212FE5-2432-494C-BED1-50583AB3AA3EQ33564323-913E6547-B155-4C4A-8F8C-9FAF8111C81EQ33908471-9B67E46C-2844-4EC1-91A0-4DB28237F9DBQ33921751-48B6AEFC-0A77-43EE-AE4D-87A58166B4B9Q34220793-2257F5C7-277C-4A56-A730-CEE6BB536939Q34503940-7F888E64-65B6-463C-85F4-FC82DBA1FB64Q34557430-D47BFB33-D1DB-4178-B7ED-7F55979B0EBCQ34590034-C89D555F-6363-4538-8069-3EE7ACDD57B5Q34607225-FB5FC3A0-DB13-40CB-AE2B-125043A7DB98Q34608713-DBB2E710-40D6-4D7F-9E42-D7006C29EB28Q35100094-DB56827C-BC29-4476-A84A-92807170E328Q35104484-49862965-56D3-42C7-905A-0307198FA6A1Q35177201-15E8A66F-9B75-4DB9-A6CF-2A5ED8E0BA5FQ35177925-9F6CEDA6-6AF2-4D50-8325-3E91861760ACQ35650609-1186F1C1-1459-422F-BA5D-86952005F683Q35774819-C44A9CE6-5208-484F-AB81-D64623FD446FQ35821169-D361759A-6236-48A6-9457-D56673F31CB2Q36074473-D65A8A7A-0667-427B-B274-FC124B09A356Q36267420-5FB90616-C7EE-4B05-8875-58F861C4BF57Q36267552-309BC1B9-FEE7-4395-9726-51BD9C785E09Q36269264-BC276F7C-8978-49BE-8323-35904631D5DBQ36269324-6BBA924D-E3ED-44DE-A65D-5D44E2EA929BQ36270640-D0E802FD-2AA9-497F-A22E-1C628D1EC861Q36271786-AD50BF57-870A-4728-BAA1-74EBB94F4E1AQ36395887-8F842F18-AD8E-4723-ADAE-5F0DDF3F0C39Q36598852-ECACB46E-8140-4D28-BFE8-8097E83C4DAEQ36673559-4B2CF028-8185-424C-A4B3-3EDF3A1BAA31Q36794012-DBB288CD-6543-4002-867E-88A636C860D0Q36862243-271DB4E2-F92B-4522-A74B-CD3DD5B4DB81
P2860
Hypersecretion of luteinising hormone, infertility, and miscarriage.
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年学术文章
@wuu
1990年学术文章
@zh-cn
1990年学术文章
@zh-hans
1990年学术文章
@zh-my
1990年学术文章
@zh-sg
1990年學術文章
@yue
1990年學術文章
@zh
1990年學術文章
@zh-hant
name
Hypersecretion of luteinising hormone, infertility, and miscarriage.
@en
Hypersecretion of luteinising hormone, infertility, and miscarriage.
@nl
type
label
Hypersecretion of luteinising hormone, infertility, and miscarriage.
@en
Hypersecretion of luteinising hormone, infertility, and miscarriage.
@nl
prefLabel
Hypersecretion of luteinising hormone, infertility, and miscarriage.
@en
Hypersecretion of luteinising hormone, infertility, and miscarriage.
@nl
P2093
P1433
P1476
Hypersecretion of luteinising hormone, infertility, and miscarriage.
@en
P2093
P304
P356
10.1016/0140-6736(90)92765-A
P407
P577
1990-11-01T00:00:00Z